The shares of AMETEK, Inc. (NYSE:AME) went up during the trading session by $0.65 on Friday, trading at $75.76. At the moment, the company has a debt-to-equity ratio of 0.42, a current ratio of 2.10, and a quick ratio of 1.40. The stock has a 52-week low of $63.14 while its 52-weeks high is $81.92. The total market cap for the stock is $17.56B while it has a PE ratio of 24.75, its price-to-earnings-growth ratio reads 3.72 while it has a beta of 1.21.
AME has flown up as the subject of gossips for a number of analysts. Analysts at Morgan Stanley Upgrade the shares of AMETEK, Inc from Equal-Weight to Overweight when they released a research note on December 18th, 2018. Stephens analysts Initiated the shares of AMETEK, Inc. to Overweight in a research note they presented on November 20th, 2018, but they now have set a price target of $87. Analysts at Stifel Reiterated the shares of AMETEK, Inc. to Buy when they released a research note on June 8th, 2017, but they now have set a price target of $69, which is an increase from the previous $66.
The current market cap of Eastman Chemical Company is valued at $11.12B. The value there would make it reasonable for the investors to decide the dimensions of Eastman Chemical Company not at all like the standard sales or statistics of their aggregate resources.
Taking a look at the current stock price for Eastman Chemical Company (NYSE:EMN), we could notice that the shares are trading close to the $78.83 level. Financial specialists have a propensity for following stock value levels in connection to their 52-week high and low levels. The 52-week high of the stock is currently $112.45 while its 52-weeks low stands at $67.40.
The performance of Eastman Chemical Company (NYSE:EMN), so far this year is at +5.99%. The performance of the stock over the past seven days has dropped by -3.13%, over the past one-month price index is 3.60% while over the last three months is -5.47%. Its six months performance has been -22.03% while for the past 52 weeks is +8.19%.
Notwithstanding that, the passion for the stock has decreased, which sees decrease in its trading volume by -23.819% below its longer-run average levels. This information shouldn’t be overlooked due to the greatly float size in the stock of 139.57M shares.
Trading at the moment with a market cap of $11.12B, EMN has a significant cash 193 million on their books, which will have to be weighed and compared to their $2.15 billion in total current liabilities. EMN is raking in trailing 12 months revenue which is around 2.55 billion. Notwithstanding that, the firm is seeing a foremost top-line progress, with their year-over-year quarterly revenue increasing by 3.30%.